{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:11:55Z","timestamp":1789668715597,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Project of the Medical and Health Science and Technology Development Research Center, National Health Commission of the People's Republic of China","award":["WKZX2024CX104101"],"award-info":[{"award-number":["WKZX2024CX104101"]}],"id":[{"id":"https:\/\/ror.org\/04bdenw41","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key Project of Young Doctor Incubation Program of the Second Affiliated Hospital of Army Medical University","award":["2024YQB024"],"award-info":[{"award-number":["2024YQB024"]}]},{"name":"Science and Health Joint Project (Mid-career and Young Elite Talent Program) from Chongqing Municipal Health Commission","award":["2023GDRC007"],"award-info":[{"award-number":["2023GDRC007"]}],"id":[{"id":"https:\/\/ror.org\/04ce5fg13","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503736"],"award-info":[{"award-number":["82503736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hospital-Level \"Disciplinary Elite\" Category I Project","award":["2023CKRC007"],"award-info":[{"award-number":["2023CKRC007"]}]},{"name":"Chongqing Natural Science Foundation","award":["CSTB2025NSCQ-LZX0045"],"award-info":[{"award-number":["CSTB2025NSCQ-LZX0045"]}]},{"name":"Scientific and Technological Research Program of Chongqing Education Commission","award":["KJQN202512815"],"award-info":[{"award-number":["KJQN202512815"]}]},{"name":"Chongqing Postdoctoral Program for Innovative Talents","award":["CQBX202426"],"award-info":[{"award-number":["CQBX202426"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20175-5","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:20:57Z","timestamp":1784722857000},"page":"9431-9441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Integrated Cell-Death Program Defines Aggressive Prostate Cancer by Coupling Ezrin to the Hippo\u2013YAP\/TAZ Axis"],"prefix":"10.1245","volume":"33","author":[{"given":"Xing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"20175_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"20175_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner MC, Zwart W, Roudier MP, et al. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol. 2021;18:79\u201392.","journal-title":"Nat Rev Urol."},{"key":"20175_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15:701\u201311.","journal-title":"Nat Rev Cancer."},{"key":"20175_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrurol.2018.22","volume":"15","author":"AH Davies","year":"2018","unstructured":"Davies AH, Beltran H, Zoubeidi A. Cellular plasticity and the neuroendocrine phenotype in prostate cancer. Nat Rev Urol. 2018;15:271\u201386.","journal-title":"Nat Rev Urol."},{"key":"20175_CR5","doi-asserted-by":"crossref","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB. Prostate cancer: a review. JAMA. 2025.","DOI":"10.1001\/jama.2025.0228"},{"key":"20175_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235\u201356.","journal-title":"Cell."},{"key":"20175_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7:286.","journal-title":"Signal Transduct Target Ther."},{"key":"20175_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364.","journal-title":"Cell Res."},{"key":"20175_CR9","doi-asserted-by":"publisher","first-page":"8813","DOI":"10.7150\/thno.62521","volume":"11","author":"S-K Hsu","year":"2021","unstructured":"Hsu S-K, Li C-Y, Lin I-L, et al. Chiu, Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021;11:8813\u201335.","journal-title":"Theranostics."},{"key":"20175_CR10","doi-asserted-by":"publisher","first-page":"107932","DOI":"10.1016\/j.pharmthera.2021.107932","volume":"228","author":"M Adamaki","year":"2021","unstructured":"Adamaki M, Zoumpourlis V. Prostate cancer biomarkers: from diagnosis to prognosis and precision-guided therapeutics. Pharmacol Ther. 2021;228:107932.","journal-title":"Pharmacol Ther."},{"key":"20175_CR11","doi-asserted-by":"publisher","first-page":"110569","DOI":"10.1016\/j.celrep.2022.110569","volume":"38","author":"JC Smith","year":"2022","unstructured":"Smith JC, Sheltzer JM. Genome-wide identification and analysis of prognostic features in human cancers. Cell Rep. 2022;38:110569.","journal-title":"Cell Rep."},{"key":"20175_CR12","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1158\/0008-5472.CAN-21-3074","volume":"82","author":"R Li","year":"2022","unstructured":"Li R, Zhu J, Zhong W-D, Jia Z. Comprehensive evaluation of machine learning models and gene expression signatures for prostate cancer prognosis using large population cohorts. Cancer Res. 2022;82:1832\u201343.","journal-title":"Cancer Res."},{"key":"20175_CR13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50:928\u201336.","journal-title":"Nat Genet."},{"key":"20175_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.5507\/bp.2025.003","volume":"169","author":"M Elias","year":"2025","unstructured":"Elias M, Bouchal J, Kral M, Kurfurstova D. Contemporary review of prognostic markers of prostate cancer from a pathologist perspective. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2025;169:149\u201360.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub."},{"key":"20175_CR15","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","volume":"317","author":"MS Litwin","year":"2017","unstructured":"Litwin MS, Tan H-J. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317:2532\u201342. https:\/\/doi.org\/10.1001\/jama.2017.7248.","journal-title":"JAMA."},{"key":"20175_CR16","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.3390\/ijms24032185","volume":"24","author":"BE Boehm","year":"2023","unstructured":"Boehm BE, York ME, Petrovics G, Kohaar I, Chesnut GT. Biomarkers of aggressive prostate cancer at diagnosis. Int J Mol Sci. 2023;24:2185.","journal-title":"Int J Mol Sci."},{"key":"20175_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/pros.24307","volume":"82","author":"F Garcia-Marques","year":"2022","unstructured":"Garcia-Marques F, Liu S, Totten SM, et al. Protein signatures to distinguish aggressive from indolent prostate cancer. Prostate. 2022;82:605\u201316.","journal-title":"Prostate."},{"key":"20175_CR18","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/cncr.34790","volume":"129","author":"AB Weiner","year":"2023","unstructured":"Weiner AB, Liu Y, Hakansson A, et al. A novel prostate cancer subtyping classifier based on luminal and basal phenotypes. Cancer. 2023;129:2169\u201378.","journal-title":"Cancer."},{"key":"20175_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131.","journal-title":"Mol Cancer."},{"key":"20175_CR20","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.7150\/thno.100555","volume":"14","author":"SB Hansen","year":"2024","unstructured":"Hansen SB, Unal B, Kuzu OF, Saatcioglu F. Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management. Theranostics. 2024;14:6913\u201334.","journal-title":"Theranostics."},{"key":"20175_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan K-L. The Hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604.","journal-title":"Annu Rev Biochem."},{"key":"20175_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/CS20201474","volume":"136","author":"R Cunningham","year":"2022","unstructured":"Cunningham R, Hansen CG. The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin Sci (Lond). 2022;136:197\u2013222.","journal-title":"Clin Sci (Lond)."},{"key":"20175_CR23","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3390\/biomedicines10112834","volume":"10","author":"F Koinis","year":"2022","unstructured":"Koinis F, Chantzara E, Samarinas M, et al. Emerging role of YAP and the Hippo pathway in prostate cancer. Biomedicines. 2022;10:2834.","journal-title":"Biomedicines."},{"key":"20175_CR24","doi-asserted-by":"publisher","first-page":"588801","DOI":"10.3389\/fcell.2020.588801","volume":"8","author":"Y Song","year":"2020","unstructured":"Song Y, Ma X, Zhang M, et al. Ezrin mediates invasion and metastasis in tumorigenesis: a review. Front Cell Dev Biol. 2020;8:588801.","journal-title":"Front Cell Dev Biol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20175-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20175-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:53:27Z","timestamp":1789667607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20175-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20175"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20175-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study followed the Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of Xinqiao Hospital and Army Medical University (No. 2024-193-02). Written informed consent was obtained from each patient.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}